Construction of Gambogic Acid HPMA Copolymer Coupling Drug System and Study on Anti-tumor Activity

Author:

Zhao Xinghua1ORCID,Ding Shi2,Li Shengnan1,Wang Yang2ORCID,Jiang Mingjun3,Liu Ju2ORCID,Chen Ye2ORCID

Affiliation:

1. Department of Medicinal, College of Pharmacy, Liaoning University, Shenyang, China

2. Department of Medicinal, College of Pharmacy, Liaoning University, Shenyang, China | Small Molecular Targeted- Drug R&D Engineering Research Center of Liaoning Province, Liaoning, China

3. Department of Medicinal, College of Pharmacy, Liaoning University, Shenyang, China | Shenyang Drug Inspection Institute, Liaoning. P.R. China

Abstract

Aim: An active-passive dual-targeting gambogic acid HPMA Copolymer Coupling drug system with high efficiency, low toxicity and high selectivity was constructed. Methods: The gambogic acid HPMA copolymer coupling drug system was constructed and its structure was characterized. The cytotoxicity of gambogic acid HPMA copolymer was detected by MTT assay. The pharmacokinetics of gambogic acid HPMA copolymer was evaluated in mice. Targetability of gambogic acid HPMA copolymer was evaluated by tissue distribution experiment. The in vitro antitumor activity of gambogic acid HPMA copolymer was evaluated by pharmacodynamics experiment in mice. Results: Two copolymers of gambogic acid HPMA were successfully prepared. The copolymers showed reduced cytotoxicity and a certain sustained release effect and targeting property. In vivo pharmacodynamic experiments also showed better anti-tumor effects than GA. Discussion: In this study, gambogic acid was combined with HPMA polymer and the targeting molecule D-galactose/folic acid to form a polymer micelle with high efficiency, low toxicity and high selectivity for active-passive dual targeting. The construction of the drug system provides new ideas for future formulation research and development.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science

Reference15 articles.

1. Chen W.Q.; Li H.; Sun K.X.; Zheng R.S.; Zhang S.W.; Zeng H.M.; Zou X.N.; Gu X.Y.; He J.; Report of cancer incidence and mortality in china, 2014. Zhonghua Zhong Liu Za Zhi 2018,40(1),5-13

2. Zhang Z.J.; Li J.H.; Chen M.J.; Synthesis and antitumor activities of novel aryl-substituted gambogic acid derivatives. Proceedings of 2017 Guangdong Pharmacist Week ConferenceGuangdong Pharmaceutical Association: Guangdong Pharmaceutical Association 2016,306-322

3. Subramanian V.; Ducept P.; Williams R. M.; Effects of photochemically activated alkylating agents of the FR900482 family on chromatin. Chem bio -london 2007,14(5),553-563

4. Ping W.U.; Hou-Qiang X.U.; Zhao J.F.; Knockdown of blm helicase promotes the sensitivity of prostate cancer pc3 cells to mitomycin C. Chin J Biochem Mol Biol 2017,33(2),190-197

5. Qian Y.; Zhang R.; Jing W.U.; Advances in antitumor mechanism of oncolytic virus and its clinical application. Tumor 2018,12,513-518

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3